Biofrontera AG (0DOL)
LSE
Closed
Sep 28, 2026
Day's Range
3.1652 wk Range
2.24Overview - 0DOL - Biofrontera AG
Key Statistics
Valuation
Enterprise Value
16.06M
P/E (Trailing)
‪0.04‬
Price / Book
‪1.13‬
EV / EBITDA
‪-25.34‬
Profitability
Profit Margin
‪-17.92%‬
Operating Margin
‪0.24%‬
Return on Assets
‪-1.95%‬
Return on Equity
‪-36.43%‬
Ownership
Shares Outstanding
44.57M
Float
1.39M
Held by Insiders
‪27.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-0.22‬
Market Cap - 0DOL - Biofrontera AG
Peers - 0DOL - Biofrontera AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0DOLLSEBiofrontera AG155.56MMarket Cap+27.22%52-week change0.04P/E (Trailing)‪-17.92%‬Profit Margin
- HLNLSEHaleon plc2.88TMarket Cap-1.07%52-week change18.76P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change7.34P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc308.38BMarket Cap-14.42%52-week change—P/E (Trailing)‪-4.92%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited187.71BMarket Cap-9.26%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB158.42BMarket Cap+36.33%52-week change45.80P/E (Trailing)‪15.54%‬Profit Margin
- 0O14LSEMerck KGaA62.53BMarket Cap+20.64%52-week change19.12P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - 0DOL - Biofrontera AG
About
Biofrontera AG is a biopharmaceutical company specializing in the development, research, and commercialization of dermatological drugs, with a strong emphasis on photodynamic therapy (PDT) for skin conditions. Headquartered in Leverkusen, Germany, and founded in 1997, the company focuses on innovative treatments for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
